CD8A and neoplasm: Although the composition of the TME was modified by the biologics treatment, with a reduction of immunosuppressive cells This was apparently not enough to reject the tumor in agreement with the absence of detectable CD8+ T cells recognizing the tumor-derived ovalbumin (Ova) antigen (data not shown).